Generated by AI
Qiagen N.V. is a biotechnology company that provides Sample to Insight solutions for molecular diagnostics, applied testing, academic research, and pharmaceutical research. Qiagen develops and markets sample preparation products, assay technologies, instruments, and bioinformatics software that help customers isolate, process, and analyze DNA, RNA, and proteins from biological materials. Its portfolio supports workflows in areas such as genotyping, gene expression, viral and bacterial analysis, next-generation sequencing, forensic testing, and clinical decision support. The company serves laboratories, healthcare organizations, research institutions, and life science companies worldwide, making it a key supplier in molecular testing and research workflows. Qiagen N.V. is headquartered in Venlo, the Netherlands, with major operational activities in Hilden, Germany.
WebsiteHulsterweg 82
Venlo, 5912 PL
Netherlands
The latest articles about QGEN.
Tipranks Press Release.
Qiagen (NYSE:QGEN) received shareholder approval at an Extraordinary General Meeting for Jonathan M. Pratt to become CEO and Managing Director. Jonathan M. Pratt is set to succeed Thierry Bernard in the top leadership role following the Extraordinary General Meeting vote. The board decision formalizes a transition at the top of Qiagen's management structure, shifting responsibilities from Thierry Bernard to Pratt. The leadership handover from Thierry Bernard to Jonathan M. Pratt is only one...
Summary of Oct 22's posts. Generated by AI.
Summary of Aug 26's posts. Generated by AI.
Qiagen has delivered a 35.3% gain over the past three years, and recent headlines around genomics partnerships and sequencing markets keep the story in focus. The question now is whether that share price trajectory lines up with what the company’s cash flows can reasonably support. With a 35.3% return over three years, Qiagen now asks investors to judge whether that run is backed by the cash its business can generate over time. New projects in areas such as precision medicine, clinical...
Summary of Aug 1's posts. Generated by AI.
Summary of Mar 3's posts. Generated by AI.
Investors talking about QGEN also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.